0001127602-24-017939.txt : 20240605
0001127602-24-017939.hdr.sgml : 20240605
20240605164511
ACCESSION NUMBER: 0001127602-24-017939
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240229
FILED AS OF DATE: 20240605
DATE AS OF CHANGE: 20240605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: APPIO THOMAS
CENTRAL INDEX KEY: 0001683323
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 241022579
MAIL ADDRESS:
STREET 1: 400 SOMERSET CORPORATE BOULEVARD
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch Health Companies Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
DATE OF NAME CHANGE: 20100928
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4/A
1
form4a.xml
PRIMARY DOCUMENT
X0508
4/A
2024-02-29
2024-03-04
0000885590
Bausch Health Companies Inc.
BHC
0001683323
APPIO THOMAS
400 SOMERSET CORPORATE BOULEVARD
BRIDGEWATER
NJ
08807
1
1
Chief Executive Officer
0
Common Shares, No Par Value
2024-02-29
4
A
0
519328
0
A
1486338
D
Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.
On March 4, 2024, the Reporting Person filed a Form 4 which, due to an inadvertent administrative error, incorrectly described the vesting schedule applicable to the grant of RSUs reported herein. This Form 4/A is being filed to correctly report the vesting schedule applicable to the RSUs, as set forth in Footnote 1 above.
/s/ Brianna M. Cetrulo, attorney-in-fact
2024-06-05